$NVCR insider trading

Over the last 12 months, NovoCure insiders reported no purchases and 8 sales totaling $940K across SEC Form 4 filings.

$940K
8
8
0%
Side
$10K$100K$1.0MJun '26JulAug
LEUNG GABRIEL
Stafford Kristin
Ocean Allyson J
Scannell Timothy J
HILLEMAN JERYL L

All insider trades

Jun 4, 2026Leonard Frank X▼ Sale34,273$17.93$615K-6.9%
Jun 2, 2026LEUNG GABRIEL▼ Sale2,945$15.77$46K-3.2%
Jun 2, 2026Stafford Kristin▼ Sale2,945$15.77$46K-20.6%
Jun 2, 2026Ocean Allyson J▼ Sale2,945$15.77$46K-20.6%
Jun 2, 2026Scannell Timothy J▼ Sale2,945$15.77$46K-17.1%
Jun 2, 2026HILLEMAN JERYL L▼ Sale2,945$15.77$46K-17.5%
Jun 2, 2026VERNON W ANTHONY▼ Sale2,945$15.77$46K-1.5%
Jun 2, 2026Hung David▼ Sale2,945$15.77$46K-12.6%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NVCR feed.

NVCR Insider Trading — Form 4 Buys & Sells | alphai